Replimune REPL
NASDAQ REPL
$15.03 -0.26 (-1.70%)
As of: Sep 4, 2026 · 2:31 PM EDT

Replimune (REPL) Retained Earnings (2018 - 2026)

Replimune (REPL) posted Retained Earnings of $5.4 million for Q1 2026, up 100.45% sequentially from -$1.2 billion in Q4 2025, and up 100.57% YoY from $2.7 million in Q1 2025.

Analysis

Replimune (REPL) Retained Earnings (2018 - 2026) Analysis & Trends

Replimune has reported Retained Earnings for 9 years, with the latest figure at $5.4 million in Q1 2026.

  • Quarterly Retained Earnings rose 100.57% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 100.57% YoY) and the FY2026 annual result came in at $5.4 million, up 100.57% from the prior year.
  • Retained Earnings climbed to $5.4 million in Q1 2026 per REPL's latest filing, from -$1.2 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at $1.4 billion in Q3 2025 and troughed at -$1.2 billion in Q4 2025.
  • A 5-year average of -$53.8 million and a median of $4.2 million in 2025 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2022 and 2025: Retained Earnings jumped 8640455.56% in 2022, then plunged 19638.19% in 2025.
  • Over 5 years, Retained Earnings stood at $1.0 billion in 2022, then grew by 3.42% to $1.1 billion in 2023, then slumped by 99.42% to $6.2 million in 2024, then slumped by 19409.99% to -$1.2 billion in 2025, then surged by 100.45% to $5.4 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered $5.4 million, -$1.2 billion, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.04 Bn 44.04 Bn - -4.00 Bn
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.41 Bn 27.57 Bn - 4.38 Bn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 6.57 Bn
10 Replimune 1.45 Bn 1.45 Bn - 1.43 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.43 Bn
Mar 31, 2026 1.42 Bn
Dec 31, 2025 1.39 Bn
Sep 30, 2025 1.38 Bn
Jun 30, 2025 1.37 Bn
Mar 31, 2025 1.36 Bn
Dec 31, 2024 1.35 Bn
Sep 30, 2024 1.19 Bn
Jun 30, 2024 1.18 Bn
Mar 31, 2024 1.07 Bn
Dec 31, 2023 1.06 Bn
Sep 30, 2023 1.05 Bn
Jun 30, 2023 1.05 Bn
Mar 31, 2023 1.03 Bn
Dec 31, 2022 1.03 Bn
Sep 30, 2022 777.65 Mn
Jun 30, 2022 763.15 Mn
Mar 31, 2022 723.36 Mn
Dec 31, 2021 717.15 Mn
Sep 30, 2021 707.19 Mn